Evidence map›Paper›PMID 39352664›Full record

ReviewGeroScience2025

Inflammation and aging-related disease: A transdisciplinary inflammaging framework.

Brian J Andonian, Joseph A Hippensteel, Katrina Abuabara, Eileen M Boyle, James F Colbert, Michael J Devinney, Adam S Faye, Bharati Kochar, Jiha Lee, Rachel Litke and 7 more

Abstract readReview
In one paragraph

Review in GeroScience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 66 papers.

0numbers the graph read from it
0cells of the map it votes in
66citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

66 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. AAV-mediated FGF21 gene therapy promotes health span extension by whole-body tissue-specific adaptations.Molecular therapy : the journal of the American Society of Gene Therapy · 2026
    Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. L-Type Voltage-Gated CaMedical sciences (Basel, Switzerland) · 2026
    Article
  18. Review
  19. Article
  20. Article

6 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Brian J Andonian *Division of Rheumatology and Immunology, Duke University School of Medicine, Durham, NC, USA. brian.andonian@duke.edu.ORCID 0000-0003-1847-0660
Joseph A Hippensteel *Division of Pulmonary Sciences and Critical Care Medicine, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.ORCID 0000-0003-4082-6993
Katrina AbuabaraDepartment of Dermatology, University of California San Francisco, San Francisco, CA, USA.ORCID 0000-0002-7736-6946
Eileen M BoyleDepartment of Haematology, University College London Cancer Institute, London, UK.ORCID 0000-0001-8791-1744
James F ColbertDivision of Infectious Diseases, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.ORCID 0000-0002-3060-2550
Michael J DevinneyDivision of Critical Care, Department of Anesthesiology, Duke University School of Medicine, Durham, NC, USA.ORCID 0000-0003-3906-6421
Adam S FayeDivision of Gastroenterology, Department of Population Health, NYU Langone Medical Center, New York, NY, USA.ORCID 0000-0002-1571-5856
Bharati KocharDivision of Gastroenterology, Massachusetts General Hospital, Boston, MA, USA.ORCID 0000-0002-8862-1236
Jiha LeeDivision of Rheumatology, Department of Internal Medicine, University of Michigan, Ann Arbor, MI, USA.ORCID 0000-0002-6402-6563
Rachel LitkeNash Family Department of Neuroscience, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Devika NairDepartment of Medicine, Division of Nephrology and Hypertension, Vanderbilt University Medical Center, Nashville, TN, USA.ORCID 0000-0001-7164-715X
Sebastian E SattuiDivision of Rheumatology and Clinical Immunology, University of Pittsburgh, Pittsburgh, PA, USA.ORCID 0000-0002-3945-6828
Anoop SheshadriDivision of Nephrology, Department of Medicine, University of California, San Francisco, Nephrology Section, San Francisco Veterans Affairs Medical Center, San Francisco, CA, USA.ORCID 0000-0002-1139-0169
Andrea N ShermanAmerican Federation for Aging Research, New York, NY, USA.
Namrata SinghDivision of Rheumatology, University of Washington, Seattle, WA, USA.ORCID 0000-0001-7149-363X
Yinan ZhangDepartment of Neurology, The Ohio State University Wexner Medical Center, Columbus, OH, USA.ORCID 0000-0001-9934-4564
Sara C LaHueDepartment of Neurology, School of Medicine, and the UCSF Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA, USA.ORCID 0000-0003-2396-7663

Funding

VARC CoreP30AG044281 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI W. JOHN BOSCARDIN · 2013 to 2026
$19.9M
Institutional Career Development Core SupplementKL2TR001870 · NCATS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI KANAYA, ALKA M., SARKAR, URMIMALA · 2016 to 2025
$19.7M
Clin-STAR Coordinating CenterU24AG065204 · NIA · AMERICAN FEDERATION FOR AGING RESEARCH · PI Thomas Michael Gill, Kristine Yaffe · 2019 to 2026
$5.5M
Incorporating Geriatric Constructs into Management of Inflammatory Bowel Diseases in Older AdultsK76AG083309 · NIA · MASSACHUSETTS GENERAL HOSPITAL · PI Bharati Kochar · 2023 to 2026
$971k
Improving shared decision-making around the use of disease modifying anti-rheumatic drugs in patients with rheumatoid arthritis and cancerK23AR079588 · NIAMS · UNIVERSITY OF WASHINGTON · PI Namrata Singh · 2022 to 2026
$821k
Lung-Brain Axis as a Mediator of DeliriumK08HL159353 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI HIPPENSTEEL, JOSEPH ALAN · 2021 to 2025
$809k
Aging-associated changes in gut microbiome drive sepsis severityK08AG061144 · NIA · UNIVERSITY OF COLORADO DENVER · PI COLBERT, JAMES F · 2019 to 2023
$799k
Understanding disease modifying antirheumatic drug use in older adults with late-onset rheumatoid arthritisK23AG082727 · NIA · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI JIHA LEE · 2023 to 2026
$778k
Optimal Preoperative Care for Older Adults with Inflammatory Bowel Disease (K76) - Resubmission - 1K76AG083286 · NIA · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI Adam Scotte Faye · 2024 to 2026
$729k
The Effect of Exercise on T Cell Aging in Rheumatoid ArthritisK23AG080066 · NIA · DUKE UNIVERSITY · PI Brian James Andonian · 2024 to 2026
$481k
Activation for Self-Care Needs in Older Adults with Chronic Kidney Disease: ACTIVE SENIORS with CKDK23DK129774 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI NAIR, DEVIKA · 2022 to 2023
$351k
Sarcopenia as a Preoperative Risk Stratification Tool Among Older Adults with Inflammatory Bowel DiseaseR03AG078927 · NIA · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI FAYE, ADAM SCOTTE · 2022 to 2023
$339k
Alzheimer's Association 23AACSF-1029536Bristol Myers Squibb Foundation Robert A. Winn Diversity in Clinical Trials Career Development AwardNational Center for Advancing Translational Sciences/National Institutes of Health KL2TR001870NCATS NIH HHS KL2 TR001870NHLBI NIH HHS K08 HL159353NHLBI NIH HHS K08HL159353NIAMS NIH HHS K23 AR079588NIA NIH HHS K08 AG061144NIA NIH HHS K08AG061144NIA NIH HHS K23 AG080066NIA NIH HHS K23 AG082727NIA NIH HHS K23AG082727NIA NIH HHS K23AR079588NIA NIH HHS K76 AG083286NIA NIH HHS K76 AG083309NIA NIH HHS K76AG083309NIA NIH HHS P30AG0287163NIA NIH HHS P30 AG044281NIA NIH HHS R03 AG067949NIA NIH HHS R03AG067949NIA NIH HHS R03 AG067976NIA NIH HHS R03AG067976NIA NIH HHS R03 AG067981NIA NIH HHS R03AG067981NIA NIH HHS R03 AG074035NIA NIH HHS R03AG074035NIA NIH HHS R03 AG074056NIA NIH HHS R03AG074056NIA NIH HHS R03 AG074059NIA NIH HHS R03AG074059NIA NIH HHS R03 AG078927NIA NIH HHS R03AG078927NIA NIH HHS R03 AG078946NIA NIH HHS R03AG078946NIA NIH HHS R03 AG078953NIA NIH HHS R03AG078953NIA NIH HHS R03 AG082857NIA NIH HHS R03AG082857NIA NIH HHS U24 AG065204NIA NIH HHS U24AG065204NIDDK NIH HHS K23 DK129774NIDDK NIH HHS K23DK129774NIGMS NIH HHS L30 GM125129
6 · The paper itself

Abstract

Inflammaging, a state of chronic, progressive low-grade inflammation during aging, is associated with several adverse clinical outcomes, including frailty, disability, and death. Chronic inflammation is a hallmark of aging and is linked to the pathogenesis of many aging-related diseases. Anti-inflammatory therapies are also increasingly being studied as potential anti-aging treatments, and clinical trials have shown benefits in selected aging-related diseases. Despite promising advances, significant gaps remain in defining, measuring, treating, and integrating inflammaging into clinical geroscience research. The Clin-STAR Inflammation Research Interest Group was formed by a group of transdisciplinary clinician-scientists with the goal of advancing inflammaging-related clinical research and improving patient-centered care for older adults. Here, we integrate insights from nine medical subspecialties to illustrate the widespread impact of inflammaging on diseases linked to aging, highlighting the extensive opportunities for targeted interventions. We then propose a transdisciplinary approach to enhance understanding and treatment of inflammaging that aims to improve comprehensive care for our aging patients.

Indexed as

AgingInflammationAgedGeroscienceHumansAging-related diseasesCellular senescenceGeriatricsInflammagingInternal medicine

Identifiers

PMID39352664
PMCPMC11872841

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.